OTC Markets OTCPK - Delayed Quote USD
BioSyent Inc. (BIOYF)
7.69
+0.12
+(1.59%)
At close: April 25 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 2.91M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
Raghubir (Sharan) Senior Officer of Issuer | Exercise of rights at price 7.75 per share. | Direct | 13,345 | Mar 31, 2025 |
Wilson, Kevin Senior Officer of Issuer | Exercise of rights at price 6.36 per share. | Direct | 12,153 | Mar 31, 2025 |
Wilson, Kevin Senior Officer of Issuer | -- | Direct | -- | Mar 31, 2025 |
Van Der Mark (Joost) Senior Officer of Issuer | Exercise of rights at price 7.75 per share. | Direct | 23,281 | Mar 31, 2025 |
Van Der Mark (Joost) Senior Officer of Issuer | -- | Direct | -- | Mar 31, 2025 |
Arcuri, Joseph Senior Officer of Issuer | -- | Direct | -- | Mar 31, 2025 |
Arcuri, Joseph Senior Officer of Issuer | Exercise of rights at price 7.75 per share. | Direct | 1,077 | Mar 31, 2025 |
Ashrafi (Seyed Ahmad) Director of Issuer | -- | Direct | -- | Mar 31, 2025 |
Ashrafi (Seyed Ahmad) Director of Issuer | Exercise of rights at price 7.75 per share. | Direct | 14,810 | Mar 31, 2025 |
Atwal (Neelu) Senior Officer of Issuer | -- | Direct | -- | Mar 31, 2025 |
Atwal (Neelu) Senior Officer of Issuer | Exercise of rights at price 7.75 per share. | Direct | 10,741 | Mar 31, 2025 |
BioSyent Inc. Issuer | -- | Direct | -- | Mar 31, 2025 |
BioSyent Inc. Issuer | -- | Indirect | -- | Mar 31, 2025 |
Elford (Sara) Director of Issuer | Exercise of rights at price 7.75 per share. | Direct | 2,015 | Mar 31, 2025 |
Goehrum (Rene Christopher) 10% Security Holder of Issuer | -- | Direct | -- | Mar 31, 2025 |
Goehrum (Rene Christopher) 10% Security Holder of Issuer | Exercise of rights at price 7.75 per share. | Direct | 61,767 | Mar 31, 2025 |
Lockhard (Peter Douglas) Director of Issuer | -- | Direct | -- | Mar 31, 2025 |
Lockhard (Peter Douglas) Director of Issuer | Exercise of rights at price 7.75 per share. | Direct | 4,363 | Mar 31, 2025 |
March (Robert Joseph) Senior Officer of Issuer | -- | Direct | -- | Mar 31, 2025 |
March (Robert Joseph) Senior Officer of Issuer | Exercise of rights at price 7.75 per share. | Direct | 23,994 | Mar 31, 2025 |
Moothan (Ramesh) Director of Issuer | Exercise of rights at price 7.75 per share. | Direct | 11,632 | Mar 31, 2025 |
Moothan (Ramesh) Director of Issuer | -- | Direct | -- | Mar 31, 2025 |
Raghubir (Sharan) Senior Officer of Issuer | -- | Direct | -- | Mar 31, 2025 |
Raghubir (Sharan) Senior Officer of Issuer | Exercise of rights at price 7.77 per share. | Direct | 19,240 | Mar 28, 2025 |
Raghubir (Sharan) Senior Officer of Issuer | Acquisition or disposition in the public market at price 7.77 per share. | Direct | 19,240 | Mar 28, 2025 |
BioSyent Inc. Issuer | Other at price 7.92 per share. | Indirect | 282,708 | Mar 27, 2025 |
BioSyent Inc. Issuer | Other at price 7.79 per share. | Indirect | 11,685 | Mar 25, 2025 |
BioSyent Inc. Issuer | Other at price 7.84 per share. | Indirect | 21,952 | Mar 21, 2025 |
Lockhard (Peter Douglas) Director of Issuer | Acquisition or disposition in the public market at price 7.84 per share. | Direct | 313 | Mar 21, 2025 |
Lockhard (Peter Douglas) Director of Issuer | Acquisition or disposition in the public market at price 7.85 per share. | Direct | 3,927 | Mar 19, 2025 |
Goehrum (Rene Christopher) 10% Security Holder of Issuer | -- | Direct | -- | Mar 18, 2025 |
Lockhard (Peter Douglas) Director of Issuer | Acquisition or disposition in the public market at price 7.87 per share. | Direct | 786 | Mar 18, 2025 |
Lockhard (Peter Douglas) Director of Issuer | -- | Direct | -- | Mar 18, 2025 |
March (Robert Joseph) Senior Officer of Issuer | -- | Direct | -- | Mar 18, 2025 |
Mccormick (Marnie) Senior Officer of Issuer | -- | Direct | -- | Mar 18, 2025 |
Moothan (Ramesh) Director of Issuer | -- | Direct | -- | Mar 18, 2025 |
Raghubir (Sharan) Senior Officer of Issuer | -- | Direct | -- | Mar 18, 2025 |
Wilton (Stephen Edwin William) Director of Issuer | -- | Direct | -- | Mar 18, 2025 |
Wilson, Kevin Senior Officer of Issuer | -- | Direct | -- | Mar 18, 2025 |
Wilson, Kevin Senior Officer of Issuer | Acquisition or disposition under a purchase/ownership plan at price 6.18 per share. | Direct | 1,415 | Mar 18, 2025 |
Wilson, Kevin Senior Officer of Issuer | Acquisition or disposition under a purchase/ownership plan at price 6.87 per share. | Direct | 6,998 | Mar 18, 2025 |
Van Der Mark (Joost) Senior Officer of Issuer | -- | Direct | -- | Mar 18, 2025 |
Arcuri, Joseph Senior Officer of Issuer | -- | Direct | -- | Mar 18, 2025 |
Ashrafi (Seyed Ahmad) Director of Issuer | -- | Direct | -- | Mar 18, 2025 |
Atwal (Neelu) Senior Officer of Issuer | -- | Direct | -- | Mar 18, 2025 |
BioSyent Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 7.61 per share. | Direct | 1,522 | Mar 14, 2025 |
BioSyent Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 7.48 per share. | Direct | 3,740 | Mar 13, 2025 |
BioSyent Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 7.52 per share. | Direct | 3,006 | Mar 12, 2025 |
BioSyent Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 7.52 per share. | Direct | 3,761 | Mar 10, 2025 |
BioSyent Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 7.58 per share. | Direct | 3,032 | Mar 7, 2025 |
Related Tickers
CPHRF Cipher Pharmaceuticals Inc.
8.95
+3.47%
VP4.F Vistin Pharma ASA
2.1000
+5.79%
SBBCF Simply Better Brands Corp.
0.6104
0.00%
CPH.TO Cipher Pharmaceuticals Inc.
12.40
+3.33%
LOVE.V Cannara Biotech Inc.
1.4000
+1.45%
AYTU Aytu BioPharma, Inc.
1.1100
+0.91%
SBBC.V Simply Better Brands Corp.
0.8500
-2.30%
HROW Harrow, Inc.
25.55
+1.91%
CRON Cronos Group Inc.
1.8000
-2.70%
ESPR Esperion Therapeutics, Inc.
0.9200
+4.39%